Wenhao Guo
Overview
Explore the profile of Wenhao Guo including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
62
Citations
554
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Yang Z, Guo Y, Guo W, Zhao M, Wang H, Wei B, et al.
Small
. 2025 Feb;
:e2409621.
PMID: 39995392
Herein, sandwich-structured hybrid flexible transparent conductive electrodes (FTCEs), implemented by sandwiching silver nanowire (AgNWs) networks between 2D TiCT MXene layers and applying pressure treatment is proposed. The synergistic effect of...
2.
Fan H, Chen W, Guo W, Han J, Xie H, Yu Y, et al.
Int Urol Nephrol
. 2025 Feb;
PMID: 39982659
Purpose: To compare intravesical instillation of gemcitabine and anthracyclines in the treatment of primary non-muscle-invasive bladder cancer (NMIBC), and to evaluate the effect of changing intravesical chemotherapy drugs on the...
3.
A real-world pharmacovigilance study of blinatumomab based on the FDA adverse event reporting system
Zhang Z, Guo W, Chen M, Yang Q, Song X, Wang Y
Expert Opin Drug Saf
. 2025 Feb;
:1-8.
PMID: 39912446
Background: Blinatumomab, the first CD3/CD19 bispecific antibody, is FDA-approved for relapsed or refractory precursor B-cell acute lymphoblastic leukemia in adults and children. This study evaluates its safety profile through pharmacovigilance...
4.
Guo W, Chen W, Zhang J, Li M, Huang H, Wang Q, et al.
BMC Cancer
. 2025 Jan;
25(1):96.
PMID: 39819319
Purpose: Renal cell carcinoma (RCC) is a common malignancy, with patients frequently diagnosed at an advanced stage due to the absence of sufficiently sensitive detection technologies, significantly compromising patient survival...
5.
Xi H, Yang X, Guo W, Pang H, Leng X, Huang X, et al.
J Colloid Interface Sci
. 2024 Dec;
683(Pt 1):860-869.
PMID: 39709760
Amidst the escalating global energy crisis, the quest for efficient electrocatalysts for water splitting has become increasingly imperative. Herein, we develop a bifunctional electrocatalyst comprising RuNi alloy nanoparticles anchored on...
6.
Cheng K, Li X, Lv W, Zhao G, Zhou R, Chang C, et al.
Signal Transduct Target Ther
. 2024 Nov;
9(1):321.
PMID: 39582060
Advanced pancreatic ductal adenocarcinoma (PDAC) has a dismal prognosis. Immunotherapy alone offers limited efficacy, but it is still unknown whether its combination with chemotherapy could offer synergistic anti-tumor effects. This...
7.
Zhang R, Lu Y, Zhang T, Liu R, Lv P, Guo W
Zhongguo Zhen Jiu
. 2024 Nov;
44(11):1294-8.
PMID: 39532447
The paper introduces professor 's clinical experience in treatment of female stress urinary incontinence. Regarding the pathogenesis of this disease, and blood deficiency, and malnutrition of (sites where the pathogens...
8.
Liu H, Pang H, Yang X, Guo W, Xi H, Ji X, et al.
Mater Horiz
. 2024 Sep;
11(22):5740-5751.
PMID: 39259046
Solar-driven interfacial evaporation has emerged as a promising avenue for clean water production, leveraging solar energy to extract water vapor from salty and polluted water sources. However, a critical challenge...
9.
Yang C, Zhang Y, Chen M, Zhu S, Tang Y, Zhang Z, et al.
Sci Bull (Beijing)
. 2024 Aug;
69(20):3216-3220.
PMID: 39217019
No abstract available.
10.
Wang J, Miao Y, Lu Z, Zhang Q, Guo W, Zhao M, et al.
ACS Appl Mater Interfaces
. 2024 Aug;
16(35):46590-46599.
PMID: 39171824
Stanene nanodots (SnNDs) derived from layered tin have attracted considerable interest due to their conveniently tunable bandgap and topological superconductivity. However, high-yield exfoliation of ultrathin SnNDs is still a challenge...